Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

Immunology Today

Volumn 18, Issue 2, 1997, Pages 89-95

  Garrido, Federico ^a   Ruiz Cabello, Francisco ^a   Cabrera, Teresa ^a   Pérez Villar, Juan J ^b   López Botet, Miguel ^b   Duggan Keen, Maggie ^c   Stern, Peter L ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

CANCER; CANCER IMMUNOTHERAPY; HLA SYSTEM; HUMAN; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOPHENOTYPING; NEOPLASMS;

EID: 0031080901     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(96)10075-X     Document Type: Review

References (67)

1. 1 Marchand, M., Weynants, P., Rankin, E. et al. (1995) Int. J. Cancer. 63, 883-885
2. 2 Mitchell, M.S., Harel, W., Kan, J. et al. (1993) Ann. New York Acad. Sci. 690, 153-166
3. 3 Melief, C.J.M. and Kast, W.M. (1994) in Vaccines Against Virally Induced Cancers (Vol. 187) (Chichester, W., ed.), pp. 97-112, Ciba Foundation Symposium
4. 4 Borysiewicz, L.K., Fiander, A., Nimako, M. et al. (1996) Lancet 347, 1523-1527
5. 5 Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F. and Stern, P. (1993) Immunol. Today 14, 491-499
6. 6 Garrido, F., Cabrera, T., López-Nevot, M.A. and Ruiz-Cabello, F. (1995) Adv. Cancer Res. 67, 155-195
7. 7 Stern, P. (1996) Adv. Cancer Res. 69, 175-211
8. 8 Townsend, A., Rothbard, J. and Gotch, F.M. (1986) Cell 44, 956-968
9. 9 Moretta, A., Bottino, C., Vitale, M. et al. (1996) Annu. Rev. Immunol. 14, 619-648
10. 10 Lanier, L.L. and Phillips, J.H. (1996) Immunol. Today 17, 86-91
11. 11 Kärre, K., Ljünggren, H.G., Piontek, G. and Kiessling, R. (1986) Nature 319, 675-678
12. 12 Garrido, F., Festenstein, H. and Schirrmacher, V. (1976) Nature 261, 705-707
13. 13 D'Urso, C.M., Wang, Z., Cao, Y., Tatake, R., Zeff, R.A. and Ferrone, S. (1991) J. Clin. Invest. 87, 284-292
14. 14 Cromme, F.J., Airey, J., Heemels, M.T. et al. (1994) J. Exp. Med. 179, 335-340
15. 15 Bonal, F.J., Pareja, E., Martín, J., Romero, C. and Garrido, F. (1986) J. Immunogenet. 13, 179-186
16. 16 Browning, M.J., Madrigal, J.A., Krausa, P. et al. (1995) Tissue Antigens 45, 177-187
17. 17 Ferrone, S. and Marincola, F.M. (1995) Immunol. Today 16, 487-494
18. 18 Browning, M., Petrozelli, F., Bicknell, D. et al. (1996) Tissue Antigens 47, 364-371
19. 19 Marincola, F.M., Shamamian, P. and Alexander, R.B. (1994) J. Immunol. 153, 1225-1237
20. 20 Torres, M.J., Ruiz-Cabello, F., Cabrera, T., Real, F.X. and Garrido, F. (1996) Tissue Antigens 47, 372-381
21. 21 Browning, M.J., Krausa, P., Rowan, A. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2842-2845
22. 22 Boon, T., Cerottini, J.C., Van den Eynde, B., van der Bruggen, P. and Van Pel, A. (1994) Annu. Rev. Immunol. 12, 337-365
23. 23 Cereb, N. and Yang, S.Y. (1994) J. Immunol. 152, 3873-3883
24. 24 Versteeg, R., Peltenburg, L.T.C., Plomp, A.C. and Schrier, P.I. (1989) J. Immunol. 143, 4331-4337
25. 25 Peltenburg, L.T. and Schrier, P.I. (1994) Immunogenetics 40, 54-61
26. 26 Redondo, M., Ruiz-Cabello, F., Cabrera, T., Oliva, M.R. and Garrido, F. (1991) Cancer Res. 51, 2463-2468
27. 27 Soong, T.W. and Hui, K.M. (1992) J. Immunol. 149, 2008-2020
28. 28 Schrier, P.I., Versteeg, R., Peltenburg, L.T. et al. (1991) Semin. Cancer Biol. 2, 73-83
29. 29 Browning, M.J., Krausa, P., Rowan, A. et al. (1993) J. Immunother. 14, 163-168
30. 30 Lehman, F., Marchand, M., Hainaut, P. et al. (1995) Eur. J. Immunol. 25, 340-347
31. 31 Cromme, F.V., Van Bommel, P., Walboomers, J.M.M. et al. (1995) Br. J. Cancer 69, 1176-1181
32. 32 Levitsky, V., Quian-Jin, Z., Levitskaya, J. and Masucci, M.G. (1996) J. Exp. Med. 183, 915-926
33. 33 Pellegrini, S., John, J., Shearer, M., Kerr, I.M. and Stark, G.R. (1989) Mol. Cell. Biol. 9, 4605-4612
34. 34 Abril, E., Serrano, A., Cabrera, T., Garrido, F. and Ruiz-Cabello, F. (1996) Tissue Antigens 47, 391-398
35. 35 Melief, C.J.M., Vasmel, W.L.E., Offringa, R. et al. (1986) Cold Spring Harbor Symp. Quant. Biol. 54, 597-603
36. 36 Wagtmann, N., Biassoni, R., Cantoni, C. et al. (1995) Immunity 2, 439-446
37. 37 Colonna, M. and Samaridis, J. (1995) Science 268, 405-408
38. 38 D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J.H. and Lanier, L.L. (1995) J. Immunol. 155, 2306-2310
39. 39 Pende, D., Biassoni, R., Cantoni, C. et al. (1996) J. Exp. Med. 184, 505-518
40. 40 Döhring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M. (1996) J. Immunol. 156, 3098-3101
41. 41 Yokoyama, W.M. (1995) Curr. Opin. Immunol. 7, 110-120
42. 42 Phillips, J.H., Chang, C., Mattson, J., Gumperz, J.E., Parham, P. and Lanier, L.L. (1996) Immunity 5, 163-172
43. 43 Aramburu, J., Balboa, M.A., Izquierdo, M. and López-Botet, M. (1991) J. Immunol. 147, 714-721
44. 44 Pérez-Villar, J.J., Carretero, M., Navarro, F. et al. J. Immunol. (in press)
45. 45 Sivori, S., Vitale, M., Bottino, C. et al. (1996) Eur. J. Immunol. 26, 2487-2492
46. 46 López-Botet, M., Moretta, L. and Strominger, J. (1996) Immunol. Today 17, 212-214
47. 47 Gumperz, J. and Parham, P. (1995) Nature 378, 245-248
48. 48 Ljunggren, H.G. and Kärre, K. (1990) Immunol. Today 11, 237-244
49. 49 Pérez, M., Algarra, I., Klein, G., Kärre, K. and Garrido, F. (1990) Int. J. Cancer 46, 258-261
50. 50 Salcedo, M., Momburg, F., Hammerling, G.J. and Ljunggren H.G. (1994) J. Immunol. 152, 1702-1708
51. 51 Malnati, M.S., Peruzzi, M., Parker, K.C. et al. (1995) Science 267, 1016-1018
52. 52 Storkus, W.J., Salter, R.D., Alexander, J. et al. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5989-5992
53. 53 Bacik, I., Cox, J.H., Anderson, R., Yewdell, J.W. and Bennink, J.R. (1994) J. Immunol. 152, 381-387
54. 54 Keating, P.J., Cromme, F.V., Duggan-Keen, M. et al. (1995) Br. J. Cancer 72, 405-411
55. 55 Pawelec, G., Silva, P., Max, H. et al. (1995) Leuk. Lymphoma 18, 471-478
56. 56 Yu, Y.Y.L., George, T., Dorfman, J.R., Roland, J., Kumar, V. and Bennett, M. (1996) Immunity 4, 67-76
57. 57 Sulitzeanu, D. (1993) Adv. Cancer Res. 60, 247-267
58. 58 Vujanovic, N.L., Polimeno, L., Azzarone, A. et al. (1995) J. Immunol. 154, 6324-6338
59. 59 Gumperz, J.E., Valiente, N.M., Parham, P. et al. (1996) J. Exp. Med. 183, 1817-1827
60. 60 Ellis, J.R.M., Keating, P.J., Baird, J. et al. (1995) Nat. Med. 1, 464-470
61. 61 Finke, J.H., Zea, A.H., Stanley, J. et al. (1993) Cancer Res. 53, 5613-5616
62. 62 Nakagomi, H., Petersson, M., Magnusson, I. et al. (1993) Cancer Res. 53, 5610-5612
63. 63 Dohlsten, M., Lando, P.A., Bjork, P. et al. (1995) Cancer Immunol. Immunother. 41, 162-168
64. 64 Cabrera, T., Fernández, M.A., Herruzo, A., Fabra, A. and Garrido, F. (1996) Hum. Immunol. 50, 127-134
65. 65 Gutierrez, J., López-Nevot, M.A., Cabrera, T., Ruiz-Cabello, F. and Garrido, F. (1987) Exp. Clin. Immunogenet. 4, 144-152
66. 66 Esteban, F., Concha, A., Pérez-Ayala, M., Ruiz-Cabello, F. and Garrido, F. (1990) Br. J. Cancer 62, 1047-1051
67. 67 Blades, R., Keating, P.J., McWilliam, L.J., George, N. and Stern, P.L. (1995) Urology 46, 681-687